H.U. Group
Our Business
Sustainability
Investor Relations

Sustainability

ESG Performance Data

Environment

Management

2021 2022 2023 2024 2025
Group companies with ISO 14001 certification 3 3 3 3 3
Group companies performing environmental audit (internal audit) 3 3 3 3 3
Group companies performing environmental audit (external audit)*1 3 3 3 3 3
Group companies performing environmental audit (audit by H.U. Group)*2 10 10 10 10 10
Employees receiving environmental training*3 10,152 9,318 6,720 9,120 9,334
Violations of environmental laws or regulations 0 0 0 0 0
  • Both internal and external audits performed at SRL and Fujirebio
  • Audit of waste disposal contractors and environmental measurement contractors of Fujirebio
  • Total number of employees receiving group-wide environmental training

Climate change

Unit 2021 2022 2023 2024 2025
CO2 emissions*1 *5
 
 
 		 Scope 1 t-CO2 14,239 14,020 8,933 7,367 6,861
Scope 2 t-CO2 29,780 34,561 32,486 28,663 29,819
Scope 3*2 Purchased goods and services t-CO2 190,790 189,570 168,419 169,124 169,260
Capital Goods t-CO2 131,413 89,069 60,418 68,757 57,935
Fuel- and energy-related activities
(not included in scope 1 or scope 2)		 t-CO2 8,176 7,408 3,711 6,017 6,539
Transportation and delivery
(upstream) 		t-CO2 4,682 4,951 4,629 4,411 5,321
Waste generated in operations t-CO2 4,101 3,850 3,948 3,114 2,541
Business travel t-CO2 1,707 1,827 1,601 1,550 1,542
Employee commuting
(including commuting by car)		 t-CO2 6,904 8,819 7,323 7,909 7,523
Upstream leased assets t-CO2 0 0 0 0 0
Transportation and delivery
(downstream)		 t-CO2 69 70 78 65 62
Processing of Sold Products t-CO2 0 0 0 0 0
Use of sold products t-CO2 16,202 17,229 1,477 1,202 927
End-of-Life Treatment of Sold Products t-CO2 1,553 1,435 1,158 778 688
Leased assets (downstream) t-CO2 6,825 7,092 6,727 6,964 5,610
Franchises t-CO2 0 0 0 0 0
Investments t-CO2 1,134 2,667 4,598 4,563 3,666
Total t-CO2 373,555 333,986 264,087 274,454 261,614
CO2 emissions Scope 1+2 t-CO2 44,019 48,581 41,420 36,030 36,680
CO2 emission intensity Scope 1+2 t-CO2 / ¥100 million
(sales) 		16.13 18.62 17.48 14.83 14.83
Energy use (intensity) GJ / ¥100 million
(sales) 		350 402 350 339 316
Consumption rate by energy type*4 Renewables
(converted to crude oil or calories)		 % 0 0 0 0 0
Fuel % 24 22 17 17 17
Electricity % 76 78 83 83 83
Carbon offset*3
Energy Use*4 Electricity GJ 740,279 829,542 803,910 684,484 649,663
City gas GJ 113,127 124,496 117,179 102,564 98,552
LPG (propane gas) GJ 2,102 2,122 2,468 2,528 2,159
Gasoline GJ 112,362 95,990 39,315 27,865 23,551
Kerosene GJ 8,569 6,767 6,408 6,412 6,257
Heavy oil GJ 860 837 636 622 747
Light oil GJ 163 493 377 0 280
Renewable energy GJ 0 0 0 0 0
Total GJ 977,461 1,062,611 970,292 824,475 781,208
  • Based on Japan’s Ministry of the Environment’s emission source unit database for calculating green gas emissions through the supply chain
  • Calculation based on GHG Protocol
  • Not disclosed at this time due to difficulty in aggregating data
  • Calculated as a crude oil conversion value

Waste

Units 2021 2022 2023 2024 2025
Waste output per sales*1･2 t / ¥100 million (sales) 1.3 1.5 1.7 1.6 1.3
Amount of waste generated*1 t 3,755 4,026 4,676 3,821 3,303
Breakdown of waste generated*1 General waste t 415 307 88 65 66
Industrial waste t 1,749 2,120 3,162 2,512 2,014
Specially controlled industrial waste t 1,591 1,599 1,426 1,244 1,223
Waste Plastic Recycling*1 % 76 86 85 86 91
Emissions of PRTR Law Class I Designated Chemical Substances*1･3 t 0.6 1.5 1.8 1.1 1.1
  • Item specialized in Japan
  • Divided by sales amount
  • Total for Fujirebio Inc. only

Water

Units 2021 2022 2023 2024 2025
Water intake*1 Thousand m3 390 420 413 383 326
Water intake per sales unit*1･2 Thousand m3 / ¥100 million
(sales)		 0.14 0.16 0.17 0.16 0.13
Water discharge*1 Thousand m3 378 407 403 373 316
Water discharge per sales unit*1･2 Thousand m3 / ¥100 million
(sales) 		0.14 0.15 0.15 0.15 0.13
COD (chemical oxygen demand)*1･3 t 0.4 0.2 0.5 0.2 0.2
  • Item specialized in Japan
  • Divided by sales amount
  • Total for Fujirebio Inc. only

Social

Customers

2021 2022 2023 2024 2025
Rate of participation in control survey and quality control reporting at medical institutions using the LUMIPULSE system 89% 89% 87% 85% 82%
Number of voluntarily recall incidents In Vitro Diagnostics business 1 1 2 3 0
Number of serious nonconformities In Vitro Diagnostics business 0 0 0 0 0
Clinical Laboratory Testing business*1 2 0 0 0 1
  • Cases requiring administrative response

Business partners

2021 2022 2023 2024 2025
Number of suppliers performing risk assessment*1 23 85 54 21 54
Percentage of suppliers performing risk assessment*1 88.5% 100% 87.1% 100.0% 100.0%
Reported cases of child labor at suppliers 0 0 0 0 0
Reported cases of forced labor at suppliers 0 0 0 0 0
  • Primary suppliers of each company and suppliers that account for the top 80% of annual procurement amounts

Employees*1

2021 2022 2023 2024 2025
Number of employees*3 Regular employees (male) 2,256 2,156 1,849 1,813 1,640
Regular employees (female) 2,083 1,948 1,633 1,557 1,560
Managers (male)*2 572 573 516 479 452
Managers (female)*2 131 146 113 109 97
Number of employees by area Japan (male) 2,570 2,474 2,365 2,292 2,092
Japan (female) 1,911 1,790 1,746 1,666 1,657
Asia (male) 2 0 0 0 0
Asia (female) 0 0 0 0 0
North America (male) 186 181 176 184 187
North America (female) 196 199 200 191 193
Europe (male) 79 79 90 89 82
Europe (female) 111 109 115 112 116
Average age 41.9 42.1 41.8 41.9 42.3
Number of employees of new graduates Male 47 25 46 37 47
Female 39 28 55 61 70
Number of new recruits of mid-career employment Male 147 210 92 94 54
Female 95 132 93 70 42
Percentage of female new recruits incl. mid-career employment 40.9% 40.5% 51.7% 50.0% 52.9%
Average years of service   11.9 13.2 13.9 14.3 14.1
Male 13.0 13.6 14.7 14.9 14.9
Female 11.3 11.8 12.9 13.3 13.1
Annual working hours per employee 1,971 2,036 1,984 1,968 1,935
Average days of paid leave taken 13 18 14 14 17
Average rate of paid leave taken 61.7% 68.1% 69.8% 66.3% 72.8%
Work-related deaths*3 0 0 0 0 0
Lost time injury frequency rate*3 3.72 1.43 0.61 0.51 0.28
Percentage of female managers*2   18.6% 20.2% 22.2% 23.5% 22.8%
Japan 12.2% 14.7% 17.8% 18.5% 17.7%
Percentage of employees with disabilities*3 2.24% 2.34% 2.51% 2.70% 2.75%
Foreign-national employees*3 17 23 22 21 30
Percentage of employees taking parental leave (including paternity leave)*3   82.3% 90.2% 88.1% 95.4%
Male 71.4% 82.5% 75.0% 90.7%
Female 100% 100% 100% 100.0% 100.0%
Percentage of employees returning to work after maternity / parental leave*3 98.8% 99.1% 94.6% 95.5% 98.6%
Employees taking family care leave (short term)*3 1 2 3 4 2
Employees taking family care leave (long term)*3 2 1 1 0 2
Average annual salary of employees(￥)*3 6,366,856 6,737,803 6,565,266 6,492,252 6,513,203
Employee turnover rate*3 10.5% 8.2% 6.3% 6.2% 5.9%
Percentage of employees undergoing medical checkup*3 87.6% 99.8% 99.0% 99.9% 99.9%
Total annual training time for all employees*3 158,215 145,092 130,682 151,281 124,441
Average annual training time per employee*3 35 32 32 34 34
Average monthly overtime hours 20.4 16.0 24.6 22.4 20.5
  • Full-time employees
  • Managers & above
  • Item specialized in Japan

Community

2021 2022 2023 2024 2025
Charitable trust fund(￥)*1 Research subsidies 239,100,000 244,100,000 249,100,000 254,100,000 259,100,000
Koichiro Fujita Award 9,000,000 9,500,000 10,000,000 10,500,000 11,000,000
Nozomu Kosakai Award 16,000,000 16,500,000 17,000,000 17,500,000 18,000,000
  • Cumulative amount for each category

Shareholders

2021 2022 2023 2024 2025
Shareholder / Investor engagement 104 112 144 134 154

Governance

Compliance

2021 2022 2023 2024 2025
Violations of anti-corruption policies and procedures 0 0 0 0 0
Fines for violations stated above (￥) 0 0 0 0 0
Cases reported to H.U. Group Hotline 116 155 184 152 192

Applicable range/period

Applicable range

Environment:
Japanese and overseas group companies

Social:
Japanese and overseas group companies

Governance:
Japanese and overseas group companies

(Except where noted)
Period Those figures are calculated based on our fiscal year.
(April 1 to March 31 of the following year)

(Except where noted)